Major industry players such as Novo Nordisk, Eli Lilly, Roche, AstraZeneca, and Pfizer are driving this trend, building diverse portfolios through a mix of internal R&D and strategic partnerships
Who should avoid IGF-1 LR3 Certain individuals should not use IGF-1 LR3 under any circumstances: Absolute Contraindications : Active cancer or history of hormone-sensitive tumors Severe diabetes or uncontrolled blood sugar Pregnancy or nursing mothers History of organ enlargement Active blood clotting disorders Relative Contraindications (may require specialty medical clearance): History of diabetes Cardiovascular conditions Autoimmune disorders Kidney or liver dysfunction History of growth disorders Before starting IGF-1 LR3, comprehensive health screening is essential
But now, that shortage is over, and the FDA says these companies that provide cheaper alternatives must stop
Similarly, some research suggests that there may be a link between GLP-1 agonists and thyroid cancer
Why can the color look uneven
The collected blood was immediately centrifuged at 3,000 g for 10 min at 4C to separate the serum, which was then stored at -80C until further analysis